Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU
- 21 February 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 316 (2) , 323-331
- https://doi.org/10.1016/j.bbrc.2004.02.050
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Pseudomonas aeruginosaBacteremia: Risk Factors for Mortality and Influence of Delayed Receipt of Effective Antimicrobial Therapy on Clinical OutcomeClinical Infectious Diseases, 2003
- Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Type III Protein Secretion Is Associated with Death in Lower Respiratory and SystemicPseudomonas aeruginosaInfectionsThe Journal of Infectious Diseases, 2001
- Type III Secretion Machines: Bacterial Devices for Protein Delivery into Host CellsScience, 1999
- PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulenceMolecular Microbiology, 1998
- ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injuryMolecular Microbiology, 1997
- Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathwayMolecular Microbiology, 1996
- Epidemiology and Outcome of Pseudomonas aeruginosa Bacteremia, With Special Emphasis on the Influence of Antibiotic TreatmentArchives of internal medicine (1960), 1996
- Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen BrushClinical Infectious Diseases, 1996
- Ventilator-Associated Pneumonia Due to Pseudomonas AeruginosaChest, 1996